Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Mar 2, 2026
Reporting period
Not applicable
Filed with the SEC
Mar 5, 2026
CEOGrant / award
Context
Classification
grant award
Code A — grant or award
Planned / mechanical clue
Footnote references vesting of compensation awards
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0001193125-26-092231
Filed / recorded
Mar 5, 2026, 2:17 AM UTC
Added to OQRO
Oct 6, 2026, 9:10 PM UTC
Parser
form4-xml-v2
Data quality
Verified: identifiers matched exactly
Issuer
Sotera Health Co
Issuer CIK
1822479
Ticker
SHC
Reporting person
Michael B. Jr. Petras
Relationship
Director, Officer
Officer title
Chairman & CEO
Security
Share Appreciation Units
Table
Derivative (Table II)
Transaction date
Mar 2, 2026
Transaction code
A
Shares / units
120,124
Price per share
$0.00
Acquired / disposed
Acquired (A)
Shares owned after
120,124
Ownership form
Direct
Amendment
No
Footnotes from the filing
These securities consist of a maximum number of SAUs that were granted on March 2, 2026, pursuant to the terms of a SAU Agreement under the 2020 Incentive Plan. Each SAU represents the Reporting Person's right to receive one share of Common Stock, subject to stock price-related peformance conditions. The SAUs generally vest annually in 60%, 20% and 20% installments, respectively, commencing March 2027, subject to performance.